JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32498

Anti-Cyclin A2 antibody [E399]

Be the first to review this product! 리뷰 제출

|

(9 제품이 사용된 논문 )

Rabbit Recombinant Monoclonal Cyclin A2 antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 9 publications.
5 이미지
Flow Cytometry - Anti-Cyclin A2 antibody [E399] (AB32498)
  • Flow Cyt

Lab

Flow Cytometry - Anti-Cyclin A2 antibody [E399] (AB32498)

Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labelling Cyclin A2 with Purified ab32498 at 1 : 30 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor™ 488, ab150077) secondary antibody was used at 1 : 2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabelled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin A2 antibody [E399] (AB32498)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin A2 antibody [E399] (AB32498)

Immunocytochemistry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Cyclin A2 with Purified ab32498 at 1/50 dilution (5.66 µg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 µg/mL). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 µg/mL) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)
  • WB

Supplier Data

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)

The smaller band is due to a tissue-specific splice variant(PMID 22745723). The band of 35kDa maybe the cleaved form(PMID : 12176996).

All lanes:

Western blot - Anti-Cyclin A2 antibody [E399] (ab32498) at 1/2000 dilution

Lane 1:

K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 15 µg

Lane 2:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 49 kDa

Observed band size: 50 kDa

false

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)
  • WB

Supplier Data

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)

Cyclin A2 is down regulated at the G2/M phase.

All lanes:

Western blot - Anti-Cyclin A2 antibody [E399] (ab32498) at 1/1000 dilution

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) lysate; Untreated, asynchronous cells (<a href='/ko/products/unavailable/hela-cell-cycle-lysates-thymidine-treated-nocodazole-treated-untreated-asynchronous-control-ab136811'>ab136811</a>) at 20 µg

Lane 2:

HeLa (Human epithelial cell line from cervix adenocarcinoma) lysate; G1/S arrested cells (thymidine treatment) (<a href='/ko/products/unavailable/hela-cell-cycle-lysates-thymidine-treated-nocodazole-treated-untreated-asynchronous-control-ab136811'>ab136811</a>) at 20 µg

Lane 3:

HeLa (Human epithelial cell line from cervix adenocarcinoma) lysate; G2/M arrested cells (sequential thymidine and nocodazole treatments) (<a href='/ko/products/unavailable/hela-cell-cycle-lysates-thymidine-treated-nocodazole-treated-untreated-asynchronous-control-ab136811'>ab136811</a>) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 49 kDa

Observed band size: 50 kDa

false

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)
  • WB

CiteAb

Western blot - Anti-Cyclin A2 antibody [E399] (AB32498)

Cyclin A2 western blot using anti-Cyclin A2 antibody [E399] ab32498. Publication image and figure legend from Wu, Z., Huang, X., et al., 2013, J Exp Clin Cancer Res, PubMed 24289849.

ab32498 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32498 please see the product overview.

B-Myb acts as the downstream effector of mir-29a to regulate cell cycle. A, the scheme of the plasmid construction for the luciferase assay. B, relative luciferase activities of the cells (with or without mir-29a over-expression) transfected with either wild or mutant 3′-UTR of B-Myb; n = 5, Mean ± SD. C, protein levels of cyclin A2, cyclin D1 and B-Myb in MDA-MB-453 cells with or without mir-29a over-expression. D, protein levels of cyclin A2, cyclin D1 and B-Myb in MCF-10A cells with or without mir-29a knockdown.

false

관련 conjugated 항체와 다양한 조성의 항체 (2)

  • Carrier free

    Anti-Cyclin A2 antibody [E399] - BSA and Azide free

  • HRP

    HRP Anti-Cyclin A2 antibody [E399]

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

E399

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IP, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Epitope

ab32498 reacts with an epitope located in the N terminal region of Cyclin A2

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/30", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>" } } }

제품 세부 정보

We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Cyclin which controls both the G1/S and the G2/M transition phases of the cell cycle. Functions through the formation of specific serine/threonine protein kinase holoenzyme complexes with the cyclin-dependent protein kinases CDK1 or CDK2. The cyclin subunit confers the substrate specificity of these complexes and differentially interacts with and activates CDK1 and CDK2 throughout the cell cycle.
See full target information CCNA2

대체 명칭 보기

CCN1, CCNA, CCNA2, Cyclin-A2, Cyclin-A, Cyclin A

제품이 사용된 논문 (9)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Cell reports 27:2990-3005.e5 PubMed31167143

2019

Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage.

Applications

Unspecified application

Species

Unspecified reactive species

David Lopez-Martinez,Marian Kupculak,Di Yang,Yasunaga Yoshikawa,Chih-Chao Liang,Ronghu Wu,Steven P Gygi,Martin A Cohn

International journal of molecular medicine 43:1395-1405 PubMed30628649

2019

Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica.

Applications

Unspecified application

Species

Unspecified reactive species

Chunsheng Yang,Yang Yang,Li Ma,Guang-Xian Zhang,Fu-Dong Shi,Yaping Yan,Guoqiang Chang

Virology 512:95-103 PubMed28946006

2017

Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus.

Applications

Unspecified application

Species

Unspecified reactive species

Satoko Iwahori,Robert F Kalejta

The Journal of biological chemistry 292:6583-6599 PubMed28289097

2017

Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Satoko Iwahori,Angie C Umaña,Halena R VanDeusen,Robert F Kalejta

Molecular medicine reports 14:3941-6 PubMed27574129

2016

Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression.

Applications

Unspecified application

Species

Unspecified reactive species

You-Yuan Zhang,Ze-Bing Liu,Xuan-Guang Ye,Wei-Min Ren

Cancer letters 351:117-25 PubMed24846301

2014

Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma.

Applications

WB

Species

Human

Xuyong Wei,Jie Li,Haiyang Xie,Qi Ling,Jianguo Wang,Di Lu,Lin Zhou,Xiao Xu,Shusen Zheng

Journal of experimental & clinical cancer research 32:98 PubMed24289849

2013

The inhibitory role of Mir-29 in growth of breast cancer cells.

Applications

WB

Species

Unspecified reactive species

Zhenglong Wu,Xiaona Huang,Xing Huang,Qiang Zou,Yujiang Guo

DNA repair 12:936-46 PubMed24041488

2013

The complexity of DNA double strand breaks is a critical factor enhancing end-resection.

Applications

Unspecified application

Species

Unspecified reactive species

Hirohiko Yajima,Hiroshi Fujisawa,Nakako Izumi Nakajima,Hirokazu Hirakawa,Penelope A Jeggo,Ryuichi Okayasu,Akira Fujimori

Cell communication and signaling : CCS 9:8 PubMed21481269

2011

A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells.

Applications

WB

Species

Unspecified reactive species

Michael J Edel,Cristina Menchon,Jose Miguel Andres Vaquero,Juan Carlos Izpisua Belmonte
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com